nothing also...

regardless if they did get it or not, tomorrow is the best opportunity for some action! all the best

Private Placement done! Let's see tomorrow

zhm540, the point is that if something of a lesser nature i.e. MDA license was 'misrepresented', the 'suggestion' that Mtouche is somewhat in discussion to get distributorship for vaccine through Shanghai Fosun's subsidiary, you're building castles in the air.

buy JAKS only laa...

haha. this is the most hyped solar stock without strong basis.

income from the sale of test kits should be prioritised. less overhead

Considering the fact that Mtouche didn't even obtain the MDA license, i think to claim stake in vaccine game is an overstretch.

haha only GETS can pull it off because of Mr Invisible. KTB needs some magic

well done mtouche for maintaining

it is coming this week

i concur InvestorJ

make your predictions today. I say a magic hand comes in to help for push to 8.5 today

yes InvestorJ, as long as there is still consistent management decision. Plus 2 weeks delay in updating news sounds more like it was deliberate so that won't get UMA for any spike from the 'misreported' news.

so Mtouche must now prevent from panic selling from a misleading news from two weeks ago. Took that long to make correction? On top of not so great QR. This is a really 'interesting' stock.

Hmm...how now?

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3110299

GG owners cashing out

profit higher than revenue, so...ok laa

hmm...whats happening today? another GETS?

and bear in mind, government still wants to collect tax so makes sense for a local distributor gets appointed. win win haha

*vaccine distributors

let's look at it this way, distributors don't sign deals with government. Of course Pfizer has to ink it to gain confidence from people. But like any deals, whoever Pfizer picks will be handling it. At this juncture it is still open for all including Mtouche.

fooh good QR! win liao

QR out loss 1.07million

https://www.thestar.com.my/news/nation/2020/11/27/pm-covid-19-vaccines-for-64mil-malaysians-next-year

one question, is Zuellig Pharma under Mtouche? if no then Pfizer vaccine game is over.

standby...

haha. i think the bintai millionaires will
soon enter mtouche to become multimillionaires

8.5 today is good also...bit by bit just like other penny stocks

wah answer like that to Bursa also can ah?

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3108630

Luster FTW! woo

this would have been the best opportunity to push price up but guess all waiting for budget vote. Standby after lunch

Those who bought on Monday maybe not so painful, but chasers would have been ticked off. Sellers for today and tomorrow are the ones i find it confusing.

looks like survived another day

between 7 and 7.5 today. Half hearted trade or a tease for what is to come next?

So this is the week. They can't afford another extension. POTUS has covid and imagine how the narrative changes for Americans who were in denial before about gloves and masks. Of course vaccine is another matter. Seize the market now MQTECH!

Or at least not yet. As long as Miss Jacqueline still holds a substantial amount of shares there is still hope.

Based on volume, dont think so. LOL

Salient points Fauzul

Perhaps it is worth taking note that Semperit was looking at selling off Latexx to TG initially. Then came MQTECH as a vehicle to relist because that is when they realise it is worth more to relist than outright selling. The extension in negotiations is a sign that Latexx deal must be concluded at a "fair' price. Bear in mind that even Hartalega believes that gloves to be in short supply till 2024. Let's just wait till the 15th.

Vienna – Semperit AG Holding is delaying the planned divestment of its Sempermed gloves business for at least another nine months on the back of “extremely positive” contribution of the unit to the Austrian group's earnings (EBITDA).

In an ad-hoc release 25 September, the Vienna-based rubber goods manufacturer revised up its outlook for full year earnings to €165-200 million, considerably higher than last year’s €68 million.

In addition to the significant contribution by Sempermed, the group said the latest upward revision reflected a ‘slight recovery’ in its industrial sector, which includes the production of hoses, conveyor belts, seals and rubber sheeting.

Accordingly, EBIT for the group is estimated to come in at €195-230 million, up from a forecast of €110-160 million earlier in July.

Semperit maintained that the earnings forecast will depend, in particular, on the further development of the price level for medical protective gloves and the sufficient availability of raw materials for their production.

The Austrian group confirmed that its strategic decision made in January to divest Sempermed and focus on industrial rubber products was still valid.

However, the group said it would continue to run the medical division for at least nine more months before “actively working on the decided separation.”

In August, Semperit reported a 47.2% year-on-year growth in half-year earnings to €57.6 million, helped by a Covid-induced boom in demand for medical gloves.

First half revenue in the Sempermed segment rose 15% to €88 million, due both to higher volumes and increased prices. Segment earnings stood at €23.0 million in the first half, following negative earnings of €300 the year before.

The business unit has two gloves production facilities in Wimpassing, Austria; and Kamunting in Malaysia, a packaging production plant in Sopron, Hungary and a gloves mould manufacturing site in Nilai, Malaysia.

vaccine it is then

the famous 1:40pm announcement is out but nothing about latexx. oh so fast things are forgotten lol

Vienna – Semperit AG will go ahead with plans to sell its rubber gloves production business, Sempermed, despite a boost in segment sales and profits in the first half of 2020.

In its results statement 14 Aug, Semperit said it considered the positive effects of the global Covid-19 pandemic on the business to be of “limited sustainability.”

Therefore, it said, the strategic decision to separate the unit and focus on the industrial rubber business in the future is still valid.

The separation, however, will be delayed, in view of the ongoing Covid pandemic and rising demand.


Sempermed lifted Semperit’s earnings and profitability significantly during the first half of 2020, despite declines in the Austrian group’s industrial sector.

Group earnings (EBITDA) increased 47.2% year-on-year to €57.6 million, helped by a boom in the medical segment. Earnings margin was up from 9.0% to 13.7% during the first six months of the year.

Semperit delayed a decision to separate its medical business in order to focus on gloves supply security in Austria in June.

Earlier in January, the Austrian group had disclosed plans to divest its Sempermed gloves making unit, as part of a strategy to focus on the industrial segment.

With two gloves production facilities in Wimpassing, Austria; and Kamunting in Malaysia, Sempermed registered sales of €88 million and earnings of €23.0 million in the first half of 2020.

In addition, the unit has a packaging production plant in Sopron, Hungary and a gloves mould manufacturing site in Nilai, Malaysia.

It really depends on their direction, i mean if i foresee next move is the vaccine production then demand of industrial gloves will surge for the manufacturers. This would weigh their decision perhaps.

https://www.semperitgroup.com/index.php?eID=tx_nawsecuredl&u=0&g=0&t=1597901212&hash=5fdd4b7b1a6ec1a86fb55ba8f3dd1a7e4446fb32&file=uploads/media/2020-08-14_Press_Release_Semperit_AG_Holding_HY_results_2020_01.pdf

"The recessive economic development and the effects of the corona crisis lead to opposing developments in the Industrial and Medical Sectors: In the medical protective gloves business, a significant increase in demand and a sharp rise in prices have been observed since the outbreak of the corona crisis. Against this background and also in view of the improved operational performance, the results of the Medical Sector in the current financial year will be significantly above the previous year’s level.

The emerging effects of the global pandemic are considered to be of limited sustainability. For this reason, the fundamental strategic decision of 28 January 2020, according to which Semperit will focus on the industrial rubber business in the future and separate from the medical business, is still valid, regardless of the developments recently observed in the wake of the corona crisis. The implementation of the separation from the medical business will be delayed."

at least a better update compared to Mqtech LOL